Cargando…

Fecal microbiota transplantation for the treatment of irritable bowel syndrome: A systematic review and meta-analysis

BACKGROUND: Irritable bowel syndrome (IBS) is the most prevalent gastrointestinal disorder in developed countries and reduces patients’ quality of life, hinders their ability to work, and increases health care costs. A growing number of trials have demonstrated an aberrant gut microbiota composition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Halkjær, Sofie Ingdam, Lo, Bobby, Cold, Frederik, Højer Christensen, Alice, Holster, Savanne, König, Julia, Brummer, Robert Jan, Aroniadis, Olga C, Lahtinen, Perttu, Holvoet, Tom, Gluud, Lise Lotte, Petersen, Andreas Munk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Meta-Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10280798/ https://www.ncbi.nlm.nih.gov/pubmed/37346153 http://dx.doi.org/10.3748/wjg.v29.i20.3185

Ejemplares similares

Engraftment of strictly anaerobic oxygen-sensitive bacteria in irritable bowel syndrome patients following fecal microbiota transplantation does not improve symptoms
por: Browne, Patrick Denis, et al.
Publicado: (2021)

Can fecal microbiota transplantation cure irritable bowel syndrome?
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2017)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis: A Systematic Review
por: Cold, Frederik, et al.
Publicado: (2020)

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome: A Randomized Controlled Study
por: Holster, Savanne, et al.
Publicado: (2019)

Allogenic Faecal Microbiota Transfer Induces Immune-Related Gene Sets in the Colon Mucosa of Patients with Irritable Bowel Syndrome
por: Holster, Savanne, et al.
Publicado: (2019)

Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting
por: König, Julia, et al.
Publicado: (2017)

Systematic review with meta-analysis: encapsulated faecal microbiota transplantation – evidence for clinical efficacy
por: Cold, Frederik, et al.
Publicado: (2021)

Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022)

Secretion of Glucose-Dependent Insulinotropic Polypeptide in Patients With Type 2 Diabetes: Systematic review and meta-analysis of clinical studies
por: Calanna, Salvatore, et al.
Publicado: (2013)

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis
por: Mirsepasi-Lauridsen, Hengameh C., et al.
Publicado: (2016)

Lacticaseibacillus rhamnosus GG Versus Placebo for Eradication of Vancomycin-Resistant Enterococcus faecium in Intestinal Carriers: A Systematic Review and Meta-Analysis
por: Rubin, Ingrid Maria Cecilia, et al.
Publicado: (2023)

Fecal microbiota transplantation for the maintenance of remission in patients with ulcerative colitis: A randomized controlled trial
por: Lahtinen, Perttu, et al.
Publicado: (2023)

Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults
por: Dai, Yun-Kai, et al.
Publicado: (2020)

Effects of probiotics (Vivomixx®) in obese pregnant women and their newborn: study protocol for a randomized controlled trial
por: Halkjaer, Sofie Ingdam, et al.
Publicado: (2016)

Is there an association between Helicobacter pylori infection and irritable bowel syndrome? A meta-analysis
por: Ng, Qin Xiang, et al.
Publicado: (2019)

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
por: Cayzeele-Decherf, Amélie, et al.
Publicado: (2017)

Celiac disease in Iranian irritable bowel syndrome patients; a systematic review and meta-analysis
por: Azami, Milad, et al.
Publicado: (2019)

Efficacy of pinaverium bromide in the treatment of irritable bowel syndrome: a systematic review and meta-analysis
por: Bor, Serhat, et al.
Publicado: (2021)

Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis
por: Wu, Irene X. Y., et al.
Publicado: (2019)

Effectiveness of Fecal Microbiota Transplantation for Weight Loss in Patients With Obesity Undergoing Bariatric Surgery: A Randomized Clinical Trial
por: Lahtinen, Perttu, et al.
Publicado: (2022)

Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis
por: Hong, Seung Wook, et al.
Publicado: (2018)

The Increased Level of Depression and Anxiety in Irritable Bowel Syndrome Patients Compared with Healthy Controls: Systematic Review and Meta-analysis
por: Lee, Changhyun, et al.
Publicado: (2017)

HTR3A and HTR3E gene polymorphisms and diarrhea predominant irritable bowel syndrome risk: evidence from a meta-analysis
por: Guan, Tangming, et al.
Publicado: (2017)

The fecal mycobiome in patients with Irritable Bowel Syndrome
por: Das, A., et al.
Publicado: (2021)

G protein beta 3(GNβ3) C825T polymorphism and irritable bowel syndrome susceptibility: an updated meta-analysis based on eleven case-control studies
por: Jiang, Dongbo, et al.
Publicado: (2017)

Multistrain Probiotic Increases the Gut Microbiota Diversity in Obese Pregnant Women: Results from a Randomized, Double-Blind Placebo-Controlled Study
por: Halkjær, Sofie Ingdam, et al.
Publicado: (2020)

Effects of adding ivabradine to usual care in patients with angina pectoris: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis
por: Maagaard, Mathias, et al.
Publicado: (2020)

Frequency of Abnormal Fecal Biomarkers in Irritable Bowel Syndrome
por: Goepp, Julius, et al.
Publicado: (2014)

Long-Term Safety Following Faecal Microbiota Transplantation as a Treatment for Recurrent Clostridioides difficile Infection Compared with Patients Treated with a Fixed Bacterial Mixture: Results from a Retrospective Cohort Study
por: Cold, Frederik, et al.
Publicado: (2022)

The effects of sodium-glucose co-transporter 2 inhibitors in patients with type 2 diabetes: protocol for a systematic review with meta-analysis of randomised trials
por: Storgaard, Heidi, et al.
Publicado: (2014)

An Investigation of Fecal Volatile Organic Metabolites in Irritable Bowel Syndrome
por: Ahmed, Iftikhar, et al.
Publicado: (2013)

Is fecal calprotectin always normal in children with irritable bowel syndrome?
por: Choi, You Jin, et al.
Publicado: (2019)

Oral and fecal microbiota in patients with diarrheal irritable bowel syndrome
por: Tang, Binbin, et al.
Publicado: (2023)

Prevalence of sleep disorder in irritable bowel syndrome: A systematic review with meta-analysis
por: Wang, Ben, et al.
Publicado: (2018)

Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis
por: Sun, Jian-Rong, et al.
Publicado: (2019)

Heterogeneity of Randomized Controlled Trials of Fecal Microbiota Transplantation in Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2021)

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials
por: Vilsbøll, Tina, et al.
Publicado: (2012)

Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome
por: Zhuang, Xiaojun, et al.
Publicado: (2018)

Research Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
por: Wang, Yao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3t7s41u6vo9d9tulov2o1aggdl